Join
Live feed
·
INSIDERFilingvia Quantisnow
AcelRx Pharmaceuticals Inc. logo

SEC Form 4: Angotti Vincent J. bought $7,950 worth of shares (10,000 units at $0.80), increasing direct ownership by 12% to 91,805 units

ByQuantisnow·Wall Street's wire, on your screen.
ACRX· AcelRx Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACRX (AcelRx Pharmaceuticals Inc.) and more on Quantisnow.